Trial Profile
An observational study assessing long term safety of Tenofovir-disoproxil-fumarate on bone mineral density in HIV infected youths
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Efavirenz
- Indications HIV infections
- Focus Adverse reactions
- 22 Apr 2016 New trial record
- 25 Feb 2016 Results presented at the 23rd Conference on Retroviruses and Opportunistic Infections.